NIH funding across 5 recipients · Louisiana
LSU NIH Funding
Louisiana State University System
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
Louisiana State University System received $88.6M in NIH award funding in fiscal year 2026 across 163 award records at 5 NIH recipients, up 4.3% from FY2025. Counted as one recipient, the group would rank #93 nationally.
LSU Health New Orleans, LSU Health Shreveport, Pennington Biomedical Research Center, LSU in Baton Rouge, and the LSU AgCenter.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NIH funding
$88.6M
+4.3% vs FY2025
Combined rank
#93
If counted as one NIH recipient · #96 in FY2025
Largest member
30%
LSU Health New Orleans, $26.3M
Awards · new projects
163
40 new Type 1 projects in FY2026
LSU NIH funding by institution, FY2026
NIH records each of these organizations as its own recipient. Ranks are each member's own national rank; follow a name for its full profile.
| Institution | FY2026 | Share | vs FY2025 | Awards | U.S. rank |
|---|---|---|---|---|---|
| LSU Health New OrleansNew Orleans, LA | $26.3M | 29.6% | +11.8% | 61 | #208 |
| Pennington Biomedical Research CenterBaton Rouge, LA | $22.7M | 25.6% | −3.9% | 30 | #219 |
| LSU Health ShreveportShreveport, LA | $21.9M | 24.7% | +28.1% | 41 | #221 |
| Louisiana State UniversityBaton Rouge, LA | $16.2M | 18.3% | −17.8% | 28 | #251 |
| LSU AgCenterBaton Rouge, LA | $1.5M | 1.7% | +48.4% | 3 | #752 |
| Subtotal | $88.6M | +4.3% | 163 |
Combined NIH funding, FY2022–FY2026
The group received $433.3M in NIH awards over these five fiscal years. Annual funding moved +3.3% from FY2022 to FY2026.
| Year | Funding | Change | Awards | Combined rank |
|---|---|---|---|---|
| FY2026 | $88.6M | +4.3% | 163 | #93 |
| FY2025 | $85.0M | +0.0% | 150 | #96 |
| FY2024 | $85.0M | −4.6% | 179 | #94 |
| FY2023 | $89.0M | +3.8% | 199 | #90 |
| FY2022 | $85.8M | — | 189 | #91 |
NIH institutes funding LSU, FY2026
The National Institute of General Medical Sciences (NIGMS) administered the most, $22.8M across 18 awards.
- NIGMS · National Institute of General Medical Sciences$22.8M · 25.7%
18 awards · vs FY2025: −2.2%
- NHLBI · National Heart, Lung, and Blood Institute$13.5M · 15.3%
26 awards · vs FY2025: +36.1%
- NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases$9.8M · 11.1%
22 awards · vs FY2025: −0.2%
- NCI · National Cancer Institute$7.5M · 8.5%
12 awards · vs FY2025: −20.2%
- NIAAA · National Institute on Alcohol Abuse and Alcoholism$6.5M · 7.4%
26 awards · vs FY2025: +4.8%
- NIAID · National Institute of Allergy and Infectious Diseases$6.3M · 7.1%
14 awards · vs FY2025: +6.6%
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development$5.4M · 6.1%
5 awards · vs FY2025: +77.8%
- NINDS · National Institute of Neurological Disorders and Stroke$3.8M · 4.2%
9 awards · vs FY2025: +130.7%
- NIA · National Institute on Aging$2.8M · 3.1%
5 awards · vs FY2025: −33.3%
- OD · NIH Office of the Director$2.4M · 2.7%
4 awards · vs FY2025: −23.0%
Also: NIDA $2.3M · NIDCD $1.6M · NIDCR $1.4M · NEI $1.0M · NIMHD $617K · NIBIB $566K · NIMH $369K · FIC $34K
Award mechanism mix
Share of NIH award dollars by activity-code family in FY2026, with the FY2022 share for comparison. R01-equivalent research grants were 47.5% of funding.
- R01-equivalent47.5% · FY22 39.2%
- Centers & program projects (P)19.4% · FY22 25.3%
- Cooperative agreements (U)15.2% · FY22 17.9%
- Other research (R)13.3% · FY22 8.6%
- Contracts (N)1.7% · FY22 2.2%
- Career development (K)1.1% · FY22 2.0%
- Fellowships (F)0.9% · FY22 0.8%
- Institutional training (T)0.9% · FY22 2.3%
- Other0.0% · FY22 1.7%
Top activity codes across LSU, FY2026
| Code | Awards | Funding | Share | Average award |
|---|---|---|---|---|
| R01 | 78 | $41.6M | 47.0% | $533K |
| P20 | 6 | $14.6M | 16.5% | $2.4M |
| UG1 | 4 | $7.7M | 8.7% | $1.9M |
| R35 | 11 | $5.0M | 5.6% | $453K |
| U54 | 4 | $4.7M | 5.3% | $1.2M |
| R21 | 12 | $3.2M | 3.6% | $268K |
| R00 | 8 | $2.0M | 2.2% | $248K |
| N01 | 2 | $1.5M | 1.7% | $752K |
| P60 | 1 | $1.4M | 1.6% | $1.4M |
| P30 | 1 | $1.2M | 1.3% | $1.2M |
| T32 | 2 | $746K | 0.8% | $373K |
| R24 | 1 | $619K | 0.7% | $619K |
Largest FY2026 awards
The biggest single award records across all members, linked to NIH RePORTER.
- Louisiana Biomedical Research Network (opens NIH RePORTER)
Louisiana State University · 5P20GM103424-25 · NIGMS
$4.1MP20
- Louisiana Clinical and Translational Science Center (opens NIH RePORTER)
Pennington Biomedical Research Center · 5U54GM104940-11 · NIGMS
$3.8MU54
- Gulf South Clinical Trials Network (Gulf South NCORP) (opens NIH RePORTER)
LSU Health New Orleans · 4UG1CA189854-12 · NCI
$2.9MUG1
- LAAZ-NPH Clinical Center (opens NIH RePORTER)
Pennington Biomedical Research Center · 3UG1HD107696-05S1 · NICHD
$2.6MUG1
- Center for Applied Immunology and Pathological Processes (opens NIH RePORTER)
LSU Health Shreveport · 2P20GM134974-06A1 · NIGMS
$2.2MP20
- Metabolic Basis of Disease - Phase 2 (opens NIH RePORTER)
Pennington Biomedical Research Center · 5P20GM135002-07 · NIGMS
$2.2MP20
Recently started projects
Recent new (Type 1) FY2026 awards across members, by notice date.
- Regulation of vascular smooth muscle phenotype by TEADs (opens NIH RePORTER)
LSU Health Shreveport · 1R01HL176881-01A1 · NHLBI · Notice Sep 18, 2026
$709KR01
- Ras signaling in type 1 regulatory T cell development and function during allergic airway inflammation (opens NIH RePORTER)
Louisiana State University · 1R21AI197492-01A1 · NIAID · Notice Sep 18, 2026
$188KR21
- FGF21 and the detection of dietary protein restriction (opens NIH RePORTER)
Pennington Biomedical Research Center · 1R01DK144477-01A1 · NIDDK · Notice Sep 9, 2026
$503KR01
- Transcriptomic effects of chronic inflammatory pain in alcohol-responsive midbrain cells (opens NIH RePORTER)
LSU Health New Orleans · 1R21AA032574-01A1 · NIAAA · Notice Sep 9, 2026
$394KR21
- Enhancing HER2-targeted therapy for refractory HER2-positive breast cancer (opens NIH RePORTER)
LSU Health New Orleans · 1R01CA317243-01 · NCI · Notice Sep 4, 2026
$521KR01
- Contribution of endoplasmic reticulum (ER) stress responses in Rickettsia pathogenesis (opens NIH RePORTER)
Louisiana State University · 1R21AI199678-01 · NIAID · Notice Sep 2, 2026
$219KR21
Other university and health systems
- Harvard University$2.04B
- Mass General Brigham$1.11B
- University of California$2.57B
- University of Texas System$1.14B
- Mayo Clinic$409.0M
- Columbia University$627.1M
- Cornell University$455.8M
- New York University$545.0M
- Vanderbilt University and VUMC$501.8M
- Penn State$183.8M
- Texas A&M University System$103.3M
- State University of New York$256.6M
- University of Massachusetts$262.4M
- University of Colorado$429.7M
- University of Illinois System$251.0M
- University System of Maryland$272.2M
- Boston University$258.2M
- Tufts University$126.5M
- Indiana University$304.4M
- Rutgers University$265.0M
- University of Miami$209.4M
- University of Connecticut$89.6M
- University of Kansas$134.4M
About these numbers
Source: the public NIH RePORTER API, refreshed October 16, 2026. See our data methodology.
- Which organizationsGotGrant groups these NIH recipient organization codes by hand. NIH does not publish system totals, so other sources may draw the boundary differently.
- Combined rankWhere the group's total would place among individual NIH recipients outside the group. NIH itself ranks each recipient separately.
- No double countingEach award has one prime recipient, so member totals add up without overlap. Subawards stay with the prime recipient, and subprojects of multi-project awards are excluded.
- What is countedTotal award amount (direct plus indirect) obligated in each fiscal year, excluding intramural research and interagency agreements.